Abstract
Extracellular vesicles (EVs) hold promise as a source of disease biomarkers. The diverse molecular cargo of EVs can potentially indicate the status of their tissue of origin, even against the complex background of whole plasma. The main tools currently available for assessing biomarkers of brain health include brain imaging and analysis of the cerebrospinal fluid of patients. Given the costs and difficulties associated with these methods, isolation of EVs of neuronal origin (NEVs) from the blood is an attractive approach to identify brain-specific biomarkers. This perspective describes current key challenges in EV- and NEV-based biomarker research. These include the relative low abundance of EVs, the lack of validated isolation methods, and the difficult search for an adequate target for immunocapturing NEVs. We discuss that these challenges must be addressed before NEVs can fulfill their potential for biomarker research.
Highlights
NEVs are promising sources of biomarkers for brain disorders.
Immunocapturing NEVs from complex biofluids presents several challenges.
The choice of surface target for capture will determine NEV yield.
Contamination by non-EV sources is relevant for biomarkers at low concentrations.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: Debora A. S. Rocha,
Luis E. Santos,
Pedro B. Da Fonseca,
Fernanda G. De Felice | July 16, 2024